OOIR: Observatory of International Research

Papers

(The median citation count of Current Opinion in Allergy and Clinical Immunology is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
What molecular allergy teaches us about genetics and epidemiology of allergies	57
The pathogenetic role of Th17 immune response in atopic dermatitis	27
The use of environmental exposure chambers in studies related to ocular surface effects	24
The collaborative medical practice of the ocular surface: a major role of the allergist/immunologist	21
Liver disease in primary antibody deficiencies	19
Anaphylaxis due to antiallergic and antiasthmatic biologics	19
E-cigarettes and asthma in adolescents	18
Is immunotherapy safe for treatment of severe asthma	18
Drug allergy awareness and perspectives with the implementation of the International Classification of Diseases-11	18
Economic burden of drug-induced anaphylaxis: what can we do better?	18
Bronchiectasis and obstructive lung diseases in primary antibody deficiencies and beyond: update on management and pathomechanisms	17
Chronic spontaneous urticaria: new evidences on the role of autoimmunity	17
New approaches in childhood asthma treatment	17
Update on occupational allergy, including asthma, to soluble platinum salts	17
Atopic manifestations of inborn errors of immunity	17
Consequences of severe asthma exacerbations	17
Editorial introductions	15
Mast cell conditions and drug allergy: when to suspect and how to manage	15
Editorial introductions	15
Real-world evidence of allergen immunotherapy	15
Neuroimmune signalling pathways in chronic rhinosinusitis with nasal polyps	15
Ocular involvement in allergic drug reactions	14
Perioperative anaphylaxis: when the allergological work-up goes negative	13
Transition of care in inborn errors of immunity	13
Epidemiology of the relationship between allergic bronchopulmonary aspergillosis and asthma	13

Paucity of gastrointestinal plasma cells in common variable immunodeficiency	13
Updates in diagnosis and management of paediatric mastocytosis	12
A review of food allergy-related costs with consideration to clinical and demographic factors	12
Is allergen immunotherapy a model of personalized treatment in pediatric respiratory allergy?	12
Editorial introductions	12
Editorial introductions	12
LNIT-Local nasal immunotherapy in allergic rhinitis: revisited evidence and perspectives	12
Food-labeling issues for severe food-allergic consumers	11
Health disparities in allergic diseases	11
Greater mechanistic understanding of the cutaneous pathogenesis of Stevens–Johnson syndrome/toxic epidermal necrolysis can shed light on novel therapeutic strategies: a comprehensive review	11
Management and treatment of perioperative hypersensitivity	11
Updates in school-based asthma management	11
Clinical remission in severe asthma: lights and shadows on an ambitious goal	10
Editorial introductions	10
Monogenic forms of common variable immunodeficiency and implications on target therapeutic approaches	10
The complexity in DNA methylation analysis of allergic diseases	10
Chronic rhinosinusitis with nasal polyps: eosinophils versus B lymphocytes in disease pathogenesis	10
Role of the ocular surface microbiome in allergic eye diseases	10
Food allergy: new therapeutic options open deeper questions	9
Precision allergy molecular diagnosis applications in food allergy	9
Do bacterial vaccines/adjuvants prevent wheezing episodes in children?	9
Biomarkers in the diagnosis of mast cell activation	9
What's new in pediatric asthma and rhinitis phenotypes and endotypes?	9
Update on hereditary C1q deficiency: pathophysiology, clinical presentation, genotype and management	9
Strengthening the case for intralymphatic immunotherapy	9
Atopic dermatitis and ocular allergy: common mechanisms and uncommon questions	8
Interstitial lung diseases in inborn errors of immunity	8
Giant cell arteritis and innovative treatments	8
The role of macrolides in chronic rhinosinusitis and nasal polyps	8
New causes of occupational allergic contact dermatitis	8
Neurotrophic keratitis: inflammatory pathogenesis and novel therapies	8
Adverse effects of anti-cancer biologics on the ocular surface	8
Pathology of T-cell-mediated drug hypersensitivity reactions and impact of tolerance mechanisms on patient susceptibility	8
Occupational respiratory allergy to reactive dyes	8
Precision medicine to personalize medicine in allergic airway disease	8
Access from healthcare professionals to evidence-based pharmacotherapy in allergy management	8
Immunobiologicals and ocular surface disease	8
Poor statistical reporting: do we have a reason for concern? A narrative review and recommendations	8
Predictive models and applicability of artificial intelligence-based approaches in drug allergy	8
Type-2-low severe asthma endotypes for new treatments: the new asthma frontier	7
MicroCrystalline Tyrosine-adsorbed immunotherapy	7
The development of the DEFASE project	7
Editorial: Pharmacotherapy and evidence based medicine	7
Endotypes of occupational asthma	7
New evidence in food allergies treatment	7
Editorial introductions	7
The risk of anaphylaxis on holidays	7
Ocular surface disorders: office procedures for the allergist/clinical immunologist	7
Transgenic murine models for the study of drug hypersensitivity reactions linked to HLA-I molecules	7
An update on patient reported outcomes in type 2 inflammation airway disease	7

New insights into the diagnosis and management of Stevens–Johnson syndrome and toxic epidermal necrolysis	7
Editorial introductions	7
Clinical outcomes of AIT in the elderly population	7
Role of biologics in severe food allergy	7
Moderate asthma: burden, mechanisms and therapeutic perspectives	7
Highlights of the treatment of allergic rhinitis according to Chinese guidelines	7
Omalizumab is the Columbus egg for food allergies	7
Diagnostic criteria of chronic conjunctivitis: atopic keratoconjunctivitis and vernal keratoconjunctivitis	6
Update on aspirin exacerbated respiratory disease with chronic rhinosinusitis	6
New insights into the mechanisms of aspirin-exacerbated respiratory disease	6
Genetic landscape of atopic dermatitis	6
Biologics and severe asthma in children	6
Editorial introductions	6
Editorial introductions	6
Diagnosis, management and therapeutic options for eosinophilic esophagitis	6
Corneal complications of rheumatoid arthritis	6
Neurostimulation for dry eye disease	6
Editorial introductions	6
Perioperative anaphylaxis: updates on pathophysiology	6
Editorial introductions	6
Recent advances in the diagnosis and management of tree nut and seed allergy	6
Global patterns of drug allergy-induced fatalities: a wake-up call to prevent avoidable deaths	5
Integrative therapeutics for ocular surface disorders	5
Biologics to treat anaphylaxis	5
Biologicals in IgE-mediated food allergy	5
STAT1 and STAT3 gain of function: clinically heterogenous immune regulatory disorders	5
Editorial introductions	5
Management of food allergy based on oral food challenge	5
Anaphylaxis: glimpse into the future, attention to the present	5
The biological basis for current treatment strategies for granulomatous disease in common variable immunodeficiency	5
Anaphylaxis in elderly people	5
Applying the new guidelines to asthma management in children	5
Chronic urticaria: not only after COVID-19 vaccination	5
The evolution of cyclosporine treatments for treatment of ocular surface diseases	5